New research finds direct link between high cholesterol and prostate cancerApril 12, 2006Researchers from Italy have found what they believe to be the first direct link between high cholesterol levels and prostate cancer. A possible association has been suggested before but evidence has been limited. This new study, published on-line (Wednesday 12 April) in Annals of Oncology[1] shows a statistically significant direct relationship between the two conditions. Lead author Dr Francesca Bravi, an epidemiologist from the Istituto di Ricerche Farmacologiche Mario Negri in Milan, said: "Although the study relied on participants' self-reported medical conditions, the absence of an association between prostate cancer and about 10 other medical conditions we investigated indicates that the relationship we found between prostate cancer and high cholesterol appears to be a real one." The research team worked on data from a case-control study carried out in four Italian areas between 1991 and 2002, involving 1,294 men under age 75 with prostate cancer and 1,451 matched controls admitted to the same hospitals with acute non-cancerous conditions. All cases and controls were interviewed in hospital by trained interviewers using wide-ranging structured questionnaires. These included a problem-oriented section on patients' medical history covering about 10 non-cancerous conditions, including hypercholesterolaemia (high cholesterol) and gallstones. Dr Bravi said: "We found that, after allowing for any potential confounding factors, men with prostate cancer were around 50% more likely to have had high cholesterol levels[2] than our non-prostate cancer controls. The association was somewhat stronger for men whose high cholesterol levels had been diagnosed before they were 50 and for men over 65, where there was an 80% greater likelihood of high cholesterol levels. We also found that prostate cancer patients were 26% more likely to have suffered from gallstones than our controls, with an apparently higher relationship in thinner men. Although that figure was not statistically significant, gallstones are often related to high cholesterol levels. To our knowledge there have been no previous studies reporting any relationship between gallstones and prostate cancer." Co-author Dr Cristina Bosetti, a senior epidemiologist and biostatistician at the same institute, explained: "Androgens - hormones that have a role in prostate tissue and cancer - are synthesised from cholesterol, suggesting a possible biological relationship between high cholesterol and prostate cancer. Gallstones are related to high cholesterol levels as well and are often composed of cholesterol. So, the direct relationship we found between gallstones and prostate cancer, while it was not statistically significant, suggests a similar biological mechanism may explain the link." This study had relied on participant's self-reporting medical conditions: the researchers believe that their results should be confirmed by further studies, including prospective investigations with reliable measured cholesterol levels. Dr Bosetti concluded: "There are some laboratory data suggesting statins may have preventive potential against prostate cancer and our results do give an indirect suggestion that statins may help in lowering prostate cancer risk. However, studies to date on cholesterol-lowering statins and prostate cancer have been limited and inconclusive." European Society for Medical Oncology |
|||||||||||||||||||||
| Related High Cholesterol Current Events and High Cholesterol News Articles Dispensing prescription drugs in 3-month supplies reduces drug costs by a third Purchasing prescription drugs in a three-month supply rather than a one-month supply has long been regarded as a way to reduce the cost of drugs for patients and third-party payers. New research from the University of Chicago quantifies the savings for the first time. Pivotal study for PSD502 -- the first potential treatment for premature ejaculation At the annual meeting of the Sexual Medicine Society of North America (SMSNA), Inc. in San Diego, Sciele Pharma, Inc., a Shionogi Company and Plethora Solutions Limited, a wholly owned subsidiary of Plethora Solutions Holdings PLC ("Plethora" - AIM:PLE)., today presented data from its second positive pivotal study of PSD502 for the treatment of premature ejaculation (PE). Study suggests dentists can identify patients at risk for fatal cardiovascular event A new study indicates dentists can play a potentially life-saving role in health care by identifying patients at risk of fatal heart attacks and referring them to physicians for further evaluation. Researchers identify the three killer indicators that are even worse than high cholesterol Researchers at the University of Warwick have identified a particular combination of health problems that can double the risk of heart attack and cause a three-fold increase in the risk of mortality. Statins show dramatic drug and cell dependent effects in the brain Besides their tremendous value in treating high cholesterol and lowering the risk of heart disease, statins have also been reported to potentially lower the risks of other diseases, such as dementia. Web-based nutrition program reduces health care costs for employees with cardiac risk factors Researchers from Boston University School of Medicine (BUSM) and Boston University School of Public Health (BUSPH) have shown that an employer-sponsored, internet-based diet and exercise program shows promise as a low-cost benefit to lower healthcare costs for those at higher risk for above-average costs and healthcare utilization such as cardiac, hyperlipidemia, hypertension or diabetes patients. These findings appear in the current issue of the Journal of Medical Internet Research. Puberty a gateway to heart disease for Canada's teens A seven-year ongoing study examining over 20,000 Canadian grade 9 students shows most already have at least one major risk factor for heart disease and stroke, Dr. Brian McCrindle told the Canadian Cardiovascular Congress 2009, co-hosted by the Heart and Stroke Foundation and the Canadian Cardiovascular Society. Learning the risks for stroke - and taking action With this theme in mind, the European Society of Cardiology (ESC) emphasises that most of the risks for stroke are also the major risks for coronary heart disease - and thus the object of the ESC's far-reaching prevention programme. Obesity may hinder optimal control of blood pressure and cholesterol Obese patients taking medications to lower their blood pressure and cholesterol levels are less likely to reach recommended targets for these cardiovascular disease risk factors than their normal weight counterparts, according to new research presented at the 2009 Canadian Cardiovascular Congress hosted by the Canadian Cardiovascular Society and the Heart and Stroke Foundation of Canada. Americans concerned about heart health, but not proactive enough to prevent it To help draw attention to National Child Health Day (today), the Preventive Cardiovascular Nurses Association (PCNA) has released findings from a new national consumer survey and launched a campaign to educate families about heart disease, the leading cause of death in the U.S. More High Cholesterol Current Events and High Cholesterol News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||